Certara Repeats Bid to Acquire Symyx | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Certara today issued a letter to Symyx's board revising its offer to acquire the company and removing any doubt that its offer provides certainty of closure.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.